LYNN GEOFFREY enters BARINTHUS BIOTHERAPEUTICS PLC. with 639.75K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 12/20/2024ACC: 0001104659-24-130804
Officer· Chief Scientific Officer
Since Dec 2024
639.75K
Baseline shares
100% direct
638.44K
Direct ownership
1 position
422.09K
Derivative underlying
4 instruments
2
Security positions
1.31K indirect
Non-Derivative Holdings2
Ordinary Shares
DirectShares owned638.44K
Ordinary Shares
IndirectShares owned1.31K
Total
638.44K direct·1.31K indirect639.75K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 638.44K | Direct |
| Ordinary Shares | 1.31K | Indirect |
| Total | 639.75K | 638.44K direct·1.31K indirect |
Derivative Holdings4
Share Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
200K
Shares owned
N/A
Exercise price
0.98
Expiration
—
Exercise window
—
Share Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
24.21K
Shares owned
N/A
Exercise price
3.70
Expiration
—
Exercise window
—
Share Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
174.50K
Shares owned
N/A
Exercise price
11.12
Expiration
—
Exercise window
—
Share Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
23.38K
Shares owned
N/A
Exercise price
2.40
Expiration
—
Exercise window
—
Total
Underlying
422.09K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Share Option (Right to Buy) Direct | Ordinary Shares | 0.98 | — | — | 200K | N/A |
| Share Option (Right to Buy) Direct | Ordinary Shares | 3.70 | — | — | 24.21K | N/A |
| Share Option (Right to Buy) Direct | Ordinary Shares | 11.12 | — | — | 174.50K | N/A |
| Share Option (Right to Buy) Direct | Ordinary Shares | 2.40 | — | — | 23.38K | N/A |
| Total | 422.09K | 0.00 | ||||